GalNAc–siURB1-AS1 specifically inhibited the expression of the lncRNA URB1-AS1 in an in vivo tumor model and significantly sensitized sorafenib-resistant HCC cells to sorafenib and inhibited tumor growth [45]. This evidence concerns the gene URB1 and neoplasm.